January 03, 2026 12:50 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Epicentre of misgovernance’: Rahul Gandhi blasts Madhya Pradesh govt over deadly water contamination | After Mamdani's letter, 8 US lawmakers push 'fair trial' for Umar Khalid amid UAPA case | ‘Bad neighbours’: Jaishankar shreds Pakistan, defends India’s right to act against cross-border terror | New Year gift for rail passengers! PM Modi to flag off first Vande Bharat sleeper in January | ‘Rs 1 lakh for his tongue’: Shah Rukh Khan faces threats after KKR signs Mushtafizur Rahman amid violence against Hindus in Bangladesh | New Year horror in Switzerland: Dozens feared dead in Crans-Montana bar explosion | Tobacco stocks crushed as govt slaps fresh excise duty from Feb 1 | Vodafone Idea shares explode 10% after surprise settlement and govt relief boost | No third party involved: India govt sources refute China’s Operation Sindoor ceasefire claim | Amit Shah blasts TMC over border fencing; Mamata fires back on Pahalgam and Delhi blast
Bangladesh Vaccine Trial

Bangladesh government rejects Chinese COVID-19 trial

| @indiablooms | Oct 15, 2020, at 06:11 pm

Dhaka: The clinical trial in Bangladesh of an experimental COVID-19 vaccine developed by Sinovac Biotech has now become uncertain after the country's health ministry expressed unwillingness towards co-financing the initiative as requested by the Chinese drugmaker.

On Sept 22, Sinovac wrote to the health minister saying they were planning to begin the phase 3 test of the vaccine candidate, CoronaVac, in August. But the firm spent the funds in another country as the Bangladesh government had delayed giving the go-ahead to the trials, reports bdnews24.

Sinovac said it was not sure about getting the final approval from Bangladesh. They appealed to the Coalition for Epidemic Preparedness Innovation or CEPI for funds to run the trial in Bangladesh but never received it, the news portal reported.

The company hence wanted the Bangladesh government to invest money to run the safety trial.

Sinovac should run the trial with their own money because that’s what they said they would do when they had sought approval, Health Minister Zahid Maleque told bdnews24

“(And) that’s why they were given permission,” he said.

“They also said they will provide us 100,000 doses of the vaccine free of charge. We approved the trial after they wrote to us following discussions on all of these issues.”

His ministry checked, first via the icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh) and then directly, with Sinovac when the planned trial of the vaccine candidate did not begin following the regulatory approval, Maleque said.

“A country’s job is done when it approves the clinical test of a vaccine. They never asked for co-funding when they sought approval for the trial. This is not a contract we have with the Chinese government. This is a private company and we cannot have a co-funding (arrangement) with a private company," the Minister said.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.